A RANDOMIZED TRIAL OF METOCLOPRAMIDE AND A COMBINATION OF DEXAMETHASONE AND LORAZEPAM FOR PREVENTION OF CHEMOTHERAPY-INDUCED VOMITING

被引：51
|
作者：
GAGEN, M
GOCHNOUR, D
YOUNG, D
GAGINELLA, T
NEIDHART, J
机构：
[1] OHIO STATE UNIV,CTR COMPREHENS CANC,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,DEPT MED,COLUMBUS,OH 43210
[3] OHIO STATE UNIV,COLL PHARM,COLUMBUS,OH 43210
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 06期
关键词：
D O I：
10.1200/JCO.1984.2.6.696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：696 / 701
页数：6
相关论文
共 50 条
  • [31] Tropisetron in the prevention of chemotherapy-induced nausea and vomiting
    Villalon, AH
    Fernando, GY
    Ysla, R
    23RD CONGRESS OF THE INTERNATIONAL SOCIETY OF INTERNAL MEDICINE, 1996, : 301 - 304
  • [32] ANTIEMETIC PROPHYLAXIS OF CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH CINNARIZINE AND LORAZEPAM
    WILDERSMITH, CH
    SENN, HJ
    ONCOLOGY, 1989, 46 (03) : 169 - 172
  • [33] Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial
    Radhakrishnan, Venkatraman
    Pai, Vishwajeeth
    Rajaraman, Swaminathan
    Mehra, Nikita
    Ganesan, Trivadi
    Dhanushkodi, Manikandan
    Perumal Kalaiyarasi, Jayachandran
    Rajan, Arun Kumar
    Selvarajan, Gangothri
    Ranganathan, Rama
    Karunakaran, Parathan
    Sagar, Tenali G.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [34] Olanzapine Versus Metoclopramide for the Treatment of Breakthrough Chemotherapy-Induced Vomiting in Children: An Open-Label, Randomized Phase 3 Trial
    Radhakrishnan, V.
    Pai, V.
    Rajaraman, S.
    Mehra, N.
    Ganesan, T.
    Dhanushkodi, M.
    Kalaiarasi, J. Perumal
    Kumar, A.
    Selvarajan, G.
    Renganathan, R.
    Sagar, T.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S1 - S1
  • [35] A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
    Rudolph M. Navari
    Lawrence H. Einhorn
    Patrick J. Loehrer
    Steven D. Passik
    Jake Vinson
    John McClean
    Naveed Chowhan
    Nasser H. Hanna
    Cynthia S. Johnson
    Supportive Care in Cancer, 2007, 15
  • [36] A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
    Navari, Rudolph M.
    Einhorn, Lawrence H.
    Loehrer, Patrick J., Sr.
    Passik, Steven D.
    Vinson, Jake
    McClean, John
    Chowhan, Naveed
    Hanna, Nasser H.
    Johnson, Cynthia S.
    SUPPORTIVE CARE IN CANCER, 2007, 15 (11) : 1285 - 1291
  • [37] CONTINUOUS INFUSION OF METOCLOPRAMIDE FOR PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS
    AGOSTINUCCI, WA
    GANNON, RH
    SCHAUER, PK
    WALTERS, JK
    CLINICAL PHARMACY, 1986, 5 (02): : 150 - 153
  • [38] Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21
    Kim, Hyo Jung
    Shin, Sang Won
    Song, Eun-Kee
    Lee, Na-Ri
    Kim, Jun Suk
    Ahn, Jin Seok
    Yun, Hwan-Jung
    Cho, Yo-Han
    Park, Keon Uk
    Kim, Si-Young
    Jang, Joung Soon
    Kim, Sang-We
    Lee, Hyun Woo
    Lee, Se Ryeon
    Kim, Yang Soo
    Lee, Soon Nam
    Ko, Yoon Ho
    Kim, Hwa Jung
    Kang, Jin-Hyoung
    ONCOLOGIST, 2015, 20 (12): : 1440 - 1447
  • [39] HIGH-DOSE METOCLOPRAMIDE IN CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    BUI, NB
    MARIT, G
    HOERNI, B
    CANCER TREATMENT REPORTS, 1982, 66 (12): : 2107 - 2108
  • [40] A RANDOMIZED DOUBLE-BLIND TRIAL OF ONDANSETRON ALONE VERSUS IN COMBINATION WITH DEXAMETHASONE VERSUS IN COMBINATION WITH DEXAMETHASONE AND LORAZEPAM IN THE PREVENTION OF EMESIS DUE TO CISPLATIN-BASED CHEMOTHERAPY
    AHN, MJ
    LEE, JS
    LEE, KH
    SUH, CW
    CHOI, SS
    KIM, SHB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (02): : 150 - 156
12345